# Lifespring Inc.

Health Center, IN
Page: https://astrelis.co/providers/health_center/151116  
This twin: https://astrelis.co/providers/health_center/151116.md  
CMS Certification Number (CCN): 151116  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2022 to 2025)

Filings that are not a full fiscal year: FY2022 covers 305 days. These years sit in no comparison pool.

- **Total patients (UDS) (FY2024):** 15,268. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total visits (all service types) (FY2024):** 92,150. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 17. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 18.9%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -45.6%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $0.2M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** -14.6%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### LifeSpring Health Systems, Inc., IN

Match to this profile: matched by name (method: name and state).

- FY ending 2025-06-30 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-06-GSAFAC-0000388883
- FY ending 2024-06-30 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-06-GSAFAC-0000065468
- FY ending 2023-06-30 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-06-GSAFAC-0000021322

| Line | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 7,299,467 [derived, p.6] | 10,558,055 [derived, p.6] | 15,351,290 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 2,389,462 [derived, p.6] | 1,937,317 [derived, p.6] | 1,848,652 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 4,216,721 [derived, p.6] | 2,667,884 [derived, p.6] | 2,370,401 [derived, p.6] |
| other current assets (Statement of financial position) | 855,590 [derived, p.6] | 778,399 [derived, p.6] | 528,371 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 14,761,240 [extracted, p.6] | 15,941,655 [extracted, p.6] | 20,098,714 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 24,211,369 [derived, p.6] | 21,983,351 [derived, p.6] | 16,396,727 [derived, p.6] |
| other long-term assets (Statement of financial position) | 4,028,431 [derived, p.6] | 3,741,653 [derived, p.6] | 3,111,433 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 43,001,040 [extracted, p.6] | 41,666,659 [extracted, p.6] | 39,819,666 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 5,160,302 [derived, p.6] | 4,222,553 [derived, p.6] | 4,301,960 [derived, p.6] |
| deferred revenue (Statement of financial position) | 1,689,321 [derived, p.6] | 1,740,362 [derived, p.6] | 1,200,000 [derived, p.6] |
| current debt and leases (Statement of financial position) | 239,142 [derived, p.6] | 297,392 [derived, p.6] | 245,514 [derived, p.6] |
| other current liabilities (Statement of financial position) | 127,560 [derived, p.6] | 512,771 [derived, p.6] | 592,583 [derived, p.6] |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 7,881,832 [extracted, p.6] | 6,773,078 [extracted, p.6] | 6,407,505 [extracted, p.6] |
| long-term debt and leases (Statement of financial position) | 2,780,585 [derived, p.6] | 137,128 [derived, p.6] | 26,767 [derived, p.6] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 10,662,417 [extracted, p.6] | 9,277,375 [extracted, p.6] | 6,579,616 [extracted, p.6] |
| net assets without donor restrictions (Statement of financial position) | 32,338,623 [derived, p.6] | 32,389,284 [derived, p.6] | 33,240,050 [derived, p.6] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 32,338,623 [extracted, p.6] | 32,389,284 [extracted, p.6] | 33,240,050 [extracted, p.6] |
| patient service revenue, net (Statement of activities) | 24,177,985 [derived, p.7] | 24,057,486 [derived, p.7] | 22,859,153 [derived, p.7] |
| pharmacy and 340B revenue (Statement of activities) | 3,736,941 [derived, p.7] | 3,948,393 [derived, p.7] | 4,145,578 [derived, p.7] |
| federal grants (Statement of activities) | 15,071,180 [derived, p.7] | 10,148,919 [derived, p.7] | 11,383,688 [derived, p.7] |
| other grants and contracts (Statement of activities) | 6,130,234 [derived, p.7] | 5,726,100 [derived, p.7] | 5,446,630 [derived, p.7] |
| contributions (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other revenue (Statement of activities) | 656,352 [derived, p.7] | 775,566 [derived, p.7] | 384,369 [derived, p.7] |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 49,772,692 [extracted, p.7] | 44,659,464 [extracted, p.7] | 44,219,418 [extracted, p.7] |
| salaries and benefits (Statement of activities) | 40,140,750 [derived, p.7] | 37,148,672 [derived, p.7] | 35,627,701 [derived, p.7] |
| supplies and pharmaceuticals (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| purchased and professional services (Statement of activities) | 2,192,379 [derived, p.7] | 1,733,349 [derived, p.7] | 1,503,906 [derived, p.7] |
| occupancy (Statement of activities) | 2,804,145 [derived, p.7] | 2,169,483 [derived, p.7] | 2,406,311 [derived, p.7] |
| depreciation and amortization (Statement of activities) | 1,470,090 [derived, p.7] | 1,221,355 [derived, p.7] | 1,065,586 [derived, p.7] |
| interest (Statement of activities) | 176,875 [derived, p.7] | 40,254 [derived, p.7] | 18,095 [derived, p.7] |
| other expenses (Statement of activities) | 3,039,114 [derived, p.7] | 3,197,117 [derived, p.7] | 2,969,805 [derived, p.7] |
| TOTAL EXPENSES (Statement of activities) | 49,823,353 [extracted, p.7] | 45,510,230 [extracted, p.7] | 43,591,404 [extracted, p.7] |
| OPERATING RESULT (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| non-operating and other changes (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| CHANGE IN NET ASSETS (Statement of activities) | -50,661 [extracted, p.7] | -850,766 [extracted, p.7] | 628,014 [extracted, p.7] |
| net assets, beginning (Statement of activities) | 32,389,284 [extracted, p.7] | 33,240,050 [extracted, p.7] | 32,612,036 [extracted, p.7] |
| net assets, end (Statement of activities) | 32,338,623 [extracted, p.7] | 32,389,284 [extracted, p.7] | 33,240,050 [extracted, p.7] |

| Ratio | FY ending 2025-06-30 | FY ending 2024-06-30 | FY ending 2023-06-30 |
|---|---:|---:|---:|
| Days cash on hand | 55 days [plausible] | 87 days [plausible] | 132 days [plausible] |
| Current ratio | 1.87x [plausible] | 2.35x [plausible] | 3.14x [plausible] |
| Operating margin | absent [not computed] | absent [not computed] | absent [not computed] |
| Total margin | -0.1% [plausible] | -1.9% [plausible] | 1.4% [plausible] |
| Patient revenue share | 48.6% [plausible] | 53.9% [plausible] | 51.7% [plausible] |
| Grant dependency | 42.6% [plausible] | 35.5% [plausible] | 38.1% [plausible] |
| Salaries share | 80.6% [plausible] | 81.6% [plausible] | 81.7% [plausible] |
| Days in patient receivables | 36 days [plausible] | 29 days [plausible] | 30 days [plausible] |
| Debt to net assets | 0.09x [plausible] | 0.01x [plausible] | 0.01x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (LifeSpring Health Systems, Inc.; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Lifespring Inc.", https://astrelis.co/providers/health_center/151116, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.